drugset / Trial / NCT06638307
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
RandomizedSequentialOpen-labelTreatment
Summary
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Timeline
- Start
- 2024-10-25
- Primary completion
- 2027-10-24
- Completion
- 2029-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elacestrant | Other / unclassified | — | Oral |
| Subject | MEN2312 | Unknown | — | Oral |